LAUSR

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the novel coronavirus disease of 2019 (COVID-19), has, to date (27 December, 2022), infected over 662 million people and been directly responsible for 6.6 million deaths worldwide [1]. Millions of patients who have recovered from COVID-19 continue to experience one or more COVID-19-related symptoms, including fatigue, intractable headaches, exertional dyspnoea, olfactory and taste disturbances, myalgia and cognitive dysfunction (also called “brain fog”) for many weeks to months following their acute illness [2]. The findings from the study reported by Mukherjee and co-workers suggest that autoreactive antibodies may be responsible for driving the inflammatory process that persist in patients with long COVID https://bit.ly/3hAnDkt